Cite
HARVARD Citation
Huijgen, R. et al. (2021). Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town. Arteriosclerosis, thrombosis, and vascular biology. 41 (2), p. . [Online].